Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)

Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)

Limited data is available for end of life care in hematologic malignancies, moreover with thrombocytopenic patients. Thrombopenia is a frequent complication, specific of bone marrow involvement in those diseases or its treatments. Yet, a few studies was interested in, whereas platelet transfusion is the only treatment indicated. As it represent a scarce, limited resource, the ethical principles are in conflict in this setting and there's a lack of recommendation. The final decision is take by the clinician and his patient, but no study exist in representation of the two parts. We provide a qualitative study to understand what this decision is made of.

Inclusion Criteria:

• major patient
• patient with advanced hematological malignancies
• patient transfused in platelet regularly (3 time at least in last month)
• medical practioner, hematologist, prescribing platelet transfusion at least one per week.
• nurse working in hematology, practicing platelet transfusion at lest one peer week.

Exclusion Criteria:

• minor patient
• non communicant patient
• non transfused platelet patient
• non voluntary patient or hematologist or nurses
• non graduated hematologist